A pilot study of low-dose zidovudine in human immunodeficiency virus infection.
about
Pathogenesis of human immunodeficiency virus infectionStability-activity relationships of a family of G-tetrad forming oligonucleotides as potent HIV inhibitors. A basis for anti-HIV drug designPhosphorylation of nucleoside analog antiretrovirals: a review for clinicians.Lack of pharmacokinetic interaction between amdoxovir and reduced- and standard-dose zidovudine in HIV-1-infected individuals.Phase I trial of valaciclovir, the L-valyl ester of acyclovir, in patients with advanced human immunodeficiency virus disease.Quantitative relationships between zidovudine exposure and efficacy and toxicityHerpes simplex virus type 2, genital ulcers and HIV-1 disease progression in postpartum women.Inhibition of immune functions by antiviral drugs.Zidovudine therapy in HIV infection: which patients should be treated and when.New drug treatments for HIV infection and AIDS. A review following the Seventh International Conference on AIDS, Florence 16-21 June 1991Zidovudine (Retrovir) updatePreventing secondary infections among HIV-positive persons.Treatment of HIV infection: the antiretroviral nucleoside analogues. Nucleoside analogues: combination therapy.Treatment of HIV infection: the antiretroviral nucleoside analogues. Nucleoside analogues: adverse effects.Treatment of HIV infection: the antiretroviral nucleoside analogues. Nucleoside analogues: monotherapy.Antiretroviral therapy: reverse transcriptase inhibition.Phase I studies of sirolimus alone or in combination with pharmacokinetic modulators in advanced cancer patients.Nail pigmentation associated with zidovudine: a review and report of a case.Zidovudine induces molecular, biochemical, and ultrastructural changes in rat skeletal muscle mitochondriaValacyclovir suppressive therapy reduces plasma and breast milk HIV-1 RNA levels during pregnancy and postpartum: a randomized trial.Effects of standard breakfast on pharmacokinetics of oral zidovudine in patients with AIDS.Strategies in the treatment of AIDS and related diseases: the lessons of cancer chemotherapy.Induction of zidovudine glucuronidation and amination pathways by rifampicin in HIV-infected patientsAntiviral therapy: current concepts and practicesIntracellular pharmacokinetics of once versus twice daily zidovudine and lamivudine in adolescents.Pharmacokinetic evaluations of low- and high-dose zidovudine plus high-dose acyclovir in patients with symptomatic human immunodeficiency virus infection.Development of an optimized dose for coformulation of zidovudine with drugs that select for the K65R mutation using a population pharmacokinetic and enzyme kinetic simulation model.Mitochondrial DNA impairment in nucleoside reverse transcriptase inhibitor-associated cardiomyopathySimultaneous quantification of 9-(beta-D-1,3-dioxolan-4-yl)guanine, Amdoxovir and Zidovudine in human plasma by liquid chromatography-tandem mass spectrometric assayMathematical modeling of the interrelationship of CD4 lymphocyte count and viral load changes induced by the protease inhibitor indinavir.Enzymatic assay for measurement of intracellular DXG triphosphate concentrations in peripheral blood mononuclear cells from human immunodeficiency virus type 1-infected patients.Management of antiretroviral drug therapy in human immunodeficiency virus infection.Treatment of human immunodeficiency virus infection and its associated complications in children.Recombinant erythropoietin for zidovudine-induced anemia in AIDS.Effects of dideoxyinosine and dideoxycytidine on the intracellular phosphorylation of zidovudine in human mononuclear cells.Zidovudine pharmacokinetics in zidovudine-induced bone marrow toxicity.Zidovudine dosage.Pharmacokinetics of Zidovudine in HIV-Positive Patients with Liver Disease
P2860
Q24634681-4E1748B0-59C4-45F9-AC67-2FBEEC076FC0Q28369425-39CADC6D-493D-40BF-891E-01EF132155F8Q31975873-4F1D6AD1-B3BC-484E-BB22-6A9EA12A37EAQ33676340-8A121B95-8296-4442-AD9B-0E20482A8D05Q33754585-F10DA638-46A6-482B-920B-29162C1F7E6DQ33756402-AD75B551-F675-4C36-A91F-A5BA92E8D2C4Q33921326-0888A373-670F-4B3C-902D-E853B44DA4D7Q34264407-3E499C2C-0D25-4FF4-8C02-494E45D4D69AQ34347587-CAF06D8B-E02D-4753-9385-AADB327922C1Q34402861-524FF9B2-0A82-4B86-AB19-376970031285Q34579638-2FB58A52-64A3-4092-9927-0C282F7E7780Q35055557-DFD56F80-411E-4BDB-B45E-84153F8E09EEQ35232016-2AB51BBA-81D4-4F70-B9ED-F03F64388DF0Q35232021-42D9B5B6-85AC-4B9F-9DCE-029870639848Q35232025-3AB8ADC0-34A9-4B95-B752-33477AF14DF2Q35322871-55854454-A500-4FB7-B491-C0F34EECF7F9Q35542196-7A422A0F-8F6C-4FE5-9E30-46812DD36A19Q35600255-3E24DD7B-E086-47E0-AC2D-6935BC132689Q35601295-21805395-40E9-4764-86B0-F39AF0FFB380Q35669036-7A344157-3372-4770-820E-F117FD7E61B5Q35897391-C32B02B2-AA2D-44DD-9E0D-0C8E31E8D084Q35930774-49C7C50C-4AE6-417C-B2AE-9301BC9E3660Q36053613-16D3ED4E-7ECB-4639-9DD4-51B2329CDA7AQ36070394-9DF8D3C8-EBF3-46D1-AC5E-CEF0DA06895FQ36095076-76C868E9-24FC-4556-91E6-6567B8033766Q36756603-69DFDD2E-115A-41DC-8803-831BE69B9224Q36993425-D6A57644-6C3D-4522-A5DC-054F9B0FFEA9Q37239515-F4B4CCF5-46F2-4325-B736-D6DB4523B8B0Q37404670-7CF5A40F-FA97-4258-A972-A3D67DA4484CQ39556704-DF047D08-3A38-4413-B0FA-ABFBE82ED649Q39730794-FC48D91C-20F8-43E0-9D9D-4BFB3E7CCCB7Q40626125-FF5668BE-334E-4419-8B9D-7A6CDEB595A4Q40727613-A1EF4208-4F73-4D2A-8285-507A22B1AA02Q40921779-612B3646-680D-4A89-810C-91DC26E91621Q41440096-E0BF1D38-8965-4F5A-8792-D2A9958DFBC7Q42264778-1BE1540A-0B64-4FA9-B424-DB4AADBB0F32Q43150455-2ED87D61-B80E-4C24-BAD0-8B4C1E988BAFQ58292513-1D828E3F-A44A-48C1-BC0D-CC82D2FEC0E9
P2860
A pilot study of low-dose zidovudine in human immunodeficiency virus infection.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh-hant
name
A pilot study of low-dose zidovudine in human immunodeficiency virus infection.
@en
A pilot study of low-dose zidovudine in human immunodeficiency virus infection.
@nl
type
label
A pilot study of low-dose zidovudine in human immunodeficiency virus infection.
@en
A pilot study of low-dose zidovudine in human immunodeficiency virus infection.
@nl
prefLabel
A pilot study of low-dose zidovudine in human immunodeficiency virus infection.
@en
A pilot study of low-dose zidovudine in human immunodeficiency virus infection.
@nl
P2093
P1476
A pilot study of low-dose zidovudine in human immunodeficiency virus infection.
@en
P2093
Bozzette S
Collier AC
Pettinelli CB
Richman DD
Schoenfeld DA
Spector SA
P304
P356
10.1056/NEJM199010113231502
P407
P577
1990-10-01T00:00:00Z